Activation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway is considered one of the major pathways involved in many viral infections, and treatment with p38 or MEK inhibitors effectively inhibits the infectivity of SARS-CoV-2 and its S protein [32,33]. This evidence concerns the gene MAP2K7 and viral infectious disease.